Form 4 for VNDA Vanda Pharmaceuticals Inc.
Accepted 2021-09-13 00:00:00 ET · period of report 2021-09-09 · accession 0001209191-21-055685 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-09-13 | 2021-09-09 | VNDA | Mitchell Stephen Ray | Dir | S - Sale+OE | $16.74 | -19.1K | 9,215 | -67% | -$319.9K |
| DM | 2021-09-13 | 2021-09-09 | VNDA | Mitchell Stephen Ray | Dir | M - OptEx | $12.03 | +19.1K | 28.3K | +207% | +$229.9K |
| DM | 2021-09-13 | 2021-09-09 | VNDA | Mitchell Stephen Ray | Dir | M - OptEx | $0.00 | -19.1K | 21.9K | -47% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-09 | S | D | 19,109 | $16.74 | 9,215 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.53 to $16.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. |
| 2 | Common | Common Stock | 2021-09-09 | M | A | 5,985 | $10.57 | 15,200 | D | — | — | |
| 3 | Common | Common Stock | 2021-09-09 | M | A | 13,124 | $12.70 | 28,324 | D | — | — | |
| 4 | Derivative | Stock Option (right to buy) | 2021-09-09 | M | D | 5,985 | $0.00 | 0 | D | $10.57 · — to 2030-06-10 | 5,985 Common Stock | (F3) This option vested and became exercisable with respect to 100% of the option shares on June 11, 2021. |
| 5 | Derivative | Stock Option (right to buy) | 2021-09-09 | M | D | 13,124 | $0.00 | 21,876 | D | $12.70 · — to 2030-02-13 | 13,124 Common Stock | (F4) The option vested with respect to 25% of the underlying shares on February 14, 2021, with the balance vesting in equal monthly installments over the next 36 months of continuous service thereafter, provided the Reporting Person provides continuous service to the Issuer through the applicable vesting date. |